TY  - BOOK
AU  - Edirisinghe,Mohan
AU  - Gultekinoglu,Merve
AU  - Ahmed,Jubair
ED  - Institute of Physics (Great Britain),
TI  - Biomaterials: innovation for world healthcare 
T2  - [IOP release $release]
SN  - 9780750351874
AV  - R857.M3 E453 2024eb
PY  - 2024///]
CY  - Bristol [England] (Temple Circus, Temple Way, Bristol BS1 6HG, UK)
PB  - IOP Publishing
KW  - Biomedical materials
KW  - Medical innovations
KW  - Biocompatible Materials
KW  - Inventions
KW  - Materials science
KW  - bicssc
KW  - TECHNOLOGY & ENGINEERING / Biomedical
KW  - bisacsh
N1  - "Version: 20240201"--Title page verso; Includes bibliographical references; 1. The concept and manufacture of a new generation of biomaterials based on global healthcare needs -- 2. Microfluidic manufacturing -- 2.1. The principles of microfluidics -- 2.2. Materials used in microfluidic chip development -- 2.3. Microfluidic chip development technologies -- 2.4. Microfluidic reactors -- 2.5. Applications of microfluidic bio-fabrication -- 2.6. Microfluidics for biological applications -- 2.7. Lab-on-a-chip diagnostic applications -- 2.8. The future scope of microfluidic technology; 3. Electrohydrodynamic manufacturing -- 3.1. The principles of electrohydrodynamics -- 3.2. Material properties used in EHD -- 3.3. Electrohydrodynamic fabrication techniques -- 3.4. Electrohydrodynamic fabrication products -- 3.5. Electrohydrodynamic technology-based biomedical engineering -- 3.6. Perspectives on the future development of electrohydrodynamic technology; 4. Gyratory processes for manufacturing -- 4.1. Centrifugal spinning -- 4.2. Pressurised gyration -- 4.3. The operating parameters of pressurised gyration -- 4.4. The physics behind pressurised gyration -- 4.5. The applications of pressurised gyration fibres -- 4.6. Materials exploited by pressurised gyration -- 4.7. The morphologies produced using pressurised gyration -- 4.8. Variants of pressurised gyration -- 4.9. The future scope of pressurised gyration; 5. Future perspectives -- 5.1. Biomaterials in healthcare -- 5.2. The future of microfluidic technologies -- 5.3. The future of electrohydrodynamic technologies -- 5.4. The future of gyration-based manufacturing techniques; Researchers, scientists, practitioners and graduate students in biomaterials, biomedical engineering, global health/medicine and humanitarian engineering; Also available in print
N2  - A biomaterial is defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostics procedures. They are used in close contact with biological systems, tissues and fluids and to serve a medical purpose, such as replacing a damaged organ or treating a disease. They play an integral role in medicine - restoring function and facilitating healing for people after injury or disease. Biomaterials may be natural or synthetic and are used in medical applications to support, enhance or replace damaged tissue or biological function. The first historical use of biomaterials dates to antiquity, when ancient Egyptians used sutures made from animal sinew. The modern field of biomaterials combine medicine, biology, physics, and chemistry and more recent influences from tissue engineering and materials science. The field has grown significantly over the past decade, largely due to discoveries in tissue engineering, regenerative medicine and more, and in this book a new generation of biomaterials; particles, capsules, microbubbles and fibres are elucidated. Part of IOP Series in Global Health and Radiation Oncology
UR  - https://iopscience.iop.org/book/mono/978-0-7503-5187-4
ER  -